drugset / Trial / NCT01063023

Drug Interaction Oral Contraceptive Pill (OCP)

NCT01063023

Phase 1 Completed 20 enrolled Bristol-Myers Squibb
Non-randomizedSingle-groupOpen-label

Summary

To assess the effects of BMS-650032 on Pharmacokinetics (PK) of ethinyl estradiol (EE) and norelgestromin (NGMN) in healthy female subjects

Timeline

Start
2010-01
Primary completion
2010-06
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Asunaprevir Small molecule 600 mg Oral
Comparator Ortho Tri-Cyclen Unknown 1 unknown Oral